H.162

An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Sponsors: Rep. Selene Colburn , Rep. Kevin Christie, Rep. Brian Cina, Rep. Mari Cordes, Rep. Nader Hashim, Rep. Lori Houghton, Rep. John Killacky, Rep. Martin LaLonde, Rep. William Lippert, Rep. Michael McCarthy, Rep. Ann Pugh, Rep. Barbara Rachelson, Rep. Maida Townsend

Last Recorded Action: 6/3/2020 - Ordered to Lie upon motion of Rep. <strong>Grad of Moretown</strong>

Committee Activity - Meeting Full List

Regular Session 2019-2020

Thursday, February 14, 2019
Committee(s):
House Committee on Judiciary
11:00 AM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Sarah George, Deputy State's Attorney, Chittenden County

Thursday, February 28, 2019
Committee(s):
House Committee on Judiciary
9:00 AM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Walk-through and Testimony

Michele Childs, Legislative Counsel, Office of Legislative Counsel
David Cahill, State's Attorney, Windsor County
David Scherr, Assistant Attorney General, Vermont Attorney General's Office
James Pepper, Deputy State's Attorney, Department of State's Attorneys & Sheriffs
Casey Daniell, Lieutenant, Department of Public Safety
Tom Dalton, Executive Director, Vermonters for Criminal Justice Reform

Thursday, March 14, 2019
Committee(s):
House Committee on Judiciary
15 Minutes After Floor

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Testimony, Committee Discussion and Possible Vote

Brandon del Pozo , Chief of Police, Burlington Police Department
Matthew Prouty, Commander, Rutland Police Department

Friday, March 15, 2019
Committee(s):
House Committee on Judiciary
15 Minutes After Floor

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Committee Discussion and Possible Vote

Michele Childs, Legislative Counsel, Office of Legislative Counsel

Wednesday, March 27, 2019
Committee(s):
House Committee on Human Services
9:00 AM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Rep. Martin LaLonde, Reporter
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Timothy Shafer, Townshend, Vermont

Friday, March 29, 2019
Committee(s):
House Committee on Human Services
1:30 PM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Mark Levine, Commissioner, Vermont Department of Health
Shayla Livingston, Public Health Policy Advisor, Department of Health
Michele Childs, Legislative Counsel, Office of Legislative Counsel
Jamie Woll, Williston

Wednesday, April 3, 2019
Committee(s):
House Committee on Human Services
-

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Michele Childs, Legislative Counsel, Office of Legislative Counsel
Deborah Richter, MD, Family Physician and Addiction Medicine Specialist
Christopher Lukonis, Gifford Addiction Medicine, Kingwood Health Center, Randolph

Thursday, April 25, 2019
Committee(s):
House Committee on Human Services
10:30 AM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Kimberly Blake, Physician, Burlington
David Hall, Legislative Counsel, Office of Legislative Counsel
Shayne Lynn, Executive Director, Champlain Valley Dispensary, Inc.
Shayla Livingston, Public Health Policy Advisor, Department of Health
Rep. John Gannon, House Committee On Government Operations
Jeffrey Wallin, Director, Vermont Information Crime Center (VCIC)
15 mins after Floor adjourns

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Michele Childs, Legislative Counsel, Office of Legislative Counsel
Rep. John Gannon, House Committee On Government Operations
Shayne Lynn, Executive Director, Champlain Valley Dispensary, Inc.
Shayla Livingston, Public Health Policy Advisor, Department of Health
Jeffrey Wallin, Director, Vermont Information Crime Center (VCIC)

Tuesday, April 30, 2019
Committee(s):
House Committee on Human Services
3:30 PM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Joshua Scharfstein, Professor of the Practice in Health Policy and Management, Johns Hopkins Bloomberg School of Public Health
Noa Krawcyzk, 4th Year Doctoral Candidate, John Hopkins Bloomberg School of Public Health

Friday, May 3, 2019
Committee(s):
House Committee on Human Services
1:00 PM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Tony Folland, Clinical Services Manager and State Opioid Treatment Authority, Department of Health
Mark Levine, Commissioner, Vermont Department of Health
Anthony Zarriello, Clinical Consultant, Washington County Treatment Court, Clinical Director, Treatment Associates, Montpelier and Morrisville

Wednesday, January 22, 2020
Committee(s):
House Committee on Human Services
9:00 AM

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Kate O'Neill, Freelance Writer
Steve Leffler, President, University of Vermont Medical Center, Vermont Medical Society President
Grace Keller, Safe Recovery Program Coordinator, Howard Center
Michele Childs, Legislative Counsel, Office of Legislative Counsel

Wednesday, March 11, 2020
Committee(s):
House Committee on Human Services
15 mins after Floor

H.162 - An act relating to removal of buprenorphine from the misdemeanor crime of possession of a narcotic

Mark-up and vote

Michele Childs, Legislative Counsel, Office of Legislative Counsel